Back to search

Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza

NCT03901001

PHASE3INTERVENTIONAL
Chinese University of Hong Kong
160 participants
Started 2023-05-08 · Completed 2025-12-31
Status: Recruiting (as of 12-23-2025)

Conditions

Influenza

Linked Papers (from SciSciNet-V2)

Total Papers0
Background
0
Result
0
Derived
0
Unknown
0

Brief Summary

Seasonal influenza epidemics are important causes of mortality and morbidity. Cytokine dysregulation, with high levels of pro-inflammatory cytokines, occurs in patients with severe influenza A(H1N1)pdm09 virus infection, A(H5N1) infection, and A(H7N9) infection. We aim to investigate the effects of adjunctive sirolimus in adults hospitalized with influenza A or B infections involving the lower respiratory tract.

No papers linked to this trial in SciSciNet

Visit ClinicalTrials.gov for more information about this study